Is Bliss GVS Pharma Ltd a good quality company?

MoneyWorks4Me analysed the past 10-year performance of Bliss GVS Pharma Ltd and arrived at the following conclusion.

Is the current market price of Bliss GVS Pharma Ltd a good price to buy it?

The 5-year analysis of Bliss GVS Pharma Ltd's performance infers.

What is Bliss GVS Pharma Ltd share price return in the past 10 years?

We analysed the performance of Bliss GVS Pharma Ltd share prices over the last 10 years. Here is what we found out:

What is a Financial Track Record? How to read this chart in order to understand the data present here?

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance

Difference between Standalone Basis and Consolidated basis? Which method is preferred for Bliss GVS Pharma Ltd

Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.

What is CAGR? What does CAGR table indicate for Bliss GVS Pharma Ltd?

Compounded average growth rate (CAGR) measures the average annual growth rate compounded year-on-year over a period of time.

Bliss GVS Pharma submits newspaper publication

Bliss GVS Pharma Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 506197 | NSE: BLISSGVS

14 Aug 2019

Evaluate

Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bliss GVS Pharma has informed about submission of the extract copies of newspaper advertisement clippings of un-audited financial results of the Company for the first quarter ended June 30, 2019 published in 'The Economic Times & The Free Press Journal' an English Daily and 'Maharashtra Times & Navshkati' a Regional Daily, on August 14, 2019.

The above information is a part of company's filings submitted to BSE.

Related Bliss GVS Pharma Ltd. Links:

Analysis

Reports

News

Stock Price

Sector News